Unlokt uses a water-soluble powder that contains clean, natural food grade ingredients. The powder can be incorporated into a range of formats, including gummies, beverages and sublinguals.
With many emulsion-based edibles, most of the cannabinoids and terpenes are metabolized by the liver when ingested. The Unlokt technology packs cannabis within a natural protein that shuttles the cannabis directly into the body's circulation by bypassing first-pass metabolism in the liver, protecting the cannabinoids and terpenes and allowing them to be released and better absorbed into the bloodstream. This delivery method offers predictable, functional effects for consumers.
"OBX has a proven track record of partnering with innovative companies and their technologies, to offer the highest quality products to our expanding global client base," said Nicole Brown, OBX chief innovation officer. "Products featuring the Unlokt technology deliver OBX's hallmark high-quality ingredients, flavors, and textures that consumers know and love, with the added benefit of providing faster onset with a consistent experience, and with clean, all-natural ingredients. We are thrilled to take product innovation in the cannabinoid category to the next level with Unlokt."
"OBX's highly trusted formulas and science-backed innovation have made them leaders in the cannabinoid industry and we are excited to count them as a valued partner," added Josh Rubin, co-founder, Day Three Labs. "Unlokt works to increase the bioavailability of rare cannabinoids that are present and already being utilized by OBX's team of scientists, and we're optimistic about the outcomes this new product line will yield for people struggling with inflammation, pain, stress and anxiety."